| Typicality: | 0.655 |
| Saliency: | 0.601 |
| after passing the neurological screening | 7 | temporal |
| within each village | 3 | location |
| after an informed consent | 3 | manner |
| subject → be included in → the study | 202 |
| subject → be included in → this study | 75 |
| subject → be included in → study | 13 |
| subject → be included in → our study | 5 |
| subject → be included into → the study | 4 |
| subject → be considered for → the study | 4 |
| negative | neutral | positive |
| 0.132 | 0.778 | 0.090 |
| Raw frequency | 303 |
| Normalized frequency | 0.601 |
| Modifier score | 0.959 |
| Perplexity | 79.071 |